Targeting immunosuppressive macrophages by CSRP2-regulated CCL28 signaling sensitizes hepatocellular carcinoma to lenvatinib

C Chen(Fudan University), Xiaowu Huang(Fudan University), Jia Li(Zhongda Hospital Southeast University), Songyang Yu(Zhejiang University), Zehuan Li(Fudan University), Yu Gong(Fudan University), Zhiqiang Hu(Jiangsu University), Xinming Ye(Fudan University), Pengcheng Wang(Fudan University), Sheng Su(Huazhong University of Science and Technology)
Journal for ImmunoTherapy of Cancer
October 1, 2025
Cited by 2


Related Papers